國立虎尾科技大學 |

Filomicelles Deliver a Chemo-Differentiative Therapy to Durably Control Carcinoma Cell Fate.

紀錄類型:	書目-語言資料,手稿 : Monograph/item
正題名/作者:	Filomicelles Deliver a Chemo-Differentiative Therapy to Durably Control Carcinoma Cell Fate./
作者:	Nair, Praful Raveendran.
面頁冊數:	1 online resource (247 pages)
附註:	Source: Dissertation Abstracts International, Volume: 79-01(E), Section: B.
Contained By:	Dissertation Abstracts International79-01B(E).
標題:	Chemical engineering. -
電子資源:	click for full text (PQDT)
ISBN:	9780355182200

Filomicelles Deliver a Chemo-Differentiative Therapy to Durably Control Carcinoma Cell Fate.
Nair, Praful Raveendran.

Filomicelles Deliver a Chemo-Differentiative Therapy to Durably Control Carcinoma Cell Fate. - 1 online resource (247 pages)

Source: Dissertation Abstracts International, Volume: 79-01(E), Section: B.

Thesis (Ph.D.)

Includes bibliographical references

Current chemotherapy causes a host of side effects and better delivery of drugs to tumors is required to reduce this. Nanocarriers have been proven to not only deliver better to tumors but also solubilize more drugs in the core, with flexible 'filomicelles' being particularly effective. They are still open to improvements and one obvious way is to increase drug loading and hence drug dosage delivered to tumors. In the first part, the core of filomicelles was modified by the integration of aromatic groups into the hydrophobic block of a degradable di-block copolymer with the aim of improving delivery of aromatic drugs. Formed by self-assembly of amphiphilic di-block copolymer PEG-PBCL, flexible worm-like micelles with an aromatic core loaded more Paclitaxel than analogous aliphatic systems. The death of cancer cells and ploidy in surviving cells were higher followed by tumor shrinkage in vivo..

Electronic reproduction.
Ann Arbor, Mich. :
ProQuest,
2018

Mode of access: World Wide Web

ISBN: 9780355182200Subjects--Topical Terms:

555952
Chemical engineering.
Index Terms--Genre/Form:

554714
Electronic books.

Filomicelles Deliver a Chemo-Differentiative Therapy to Durably Control Carcinoma Cell Fate.
LDR:03711ntm a2200373Ki 4500 001 910498
005 20180517123956.5
006 m o u
007 cr mn||||a|a||
008 190606s2017 xx obm 000 0 eng d
020 $a 9780355182200
035 $a (MiAaPQ)AAI10600957
035 $a (MiAaPQ)upenngdas:12850
035 $a AAI10600957
040 $a MiAaPQ $b eng $c MiAaPQ
099 $a TUL $f hyy $c available through World Wide Web
100 1 $a Nair, Praful Raveendran. $3 1181823
245 1 0 $a Filomicelles Deliver a Chemo-Differentiative Therapy to Durably Control Carcinoma Cell Fate.
264 0 $c 2017
300 $a 1 online resource (247 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Dissertation Abstracts International, Volume: 79-01(E), Section: B.
500 $a Adviser: Dennis E. Discher.
502 $a Thesis (Ph.D.) $c University of Pennsylvania $d 2017.
504 $a Includes bibliographical references
520 $a Current chemotherapy causes a host of side effects and better delivery of drugs to tumors is required to reduce this. Nanocarriers have been proven to not only deliver better to tumors but also solubilize more drugs in the core, with flexible 'filomicelles' being particularly effective. They are still open to improvements and one obvious way is to increase drug loading and hence drug dosage delivered to tumors. In the first part, the core of filomicelles was modified by the integration of aromatic groups into the hydrophobic block of a degradable di-block copolymer with the aim of improving delivery of aromatic drugs. Formed by self-assembly of amphiphilic di-block copolymer PEG-PBCL, flexible worm-like micelles with an aromatic core loaded more Paclitaxel than analogous aliphatic systems. The death of cancer cells and ploidy in surviving cells were higher followed by tumor shrinkage in vivo..
520 $a When cancer cells are treated with single drugs alone during chemotherapy, development of drug resistance has been commonly noted, eventually leading to relapse. Retinoic acid (RA) induces differentiation and proliferation arrest in many cell types. With carcinoma lines, we find dual drug treatment with RA and Paclitaxel increases ploidy and cell death beyond those achieved by either drug single-handedly, with effects being durable. A month after treatment, relapse rates are low for RA-TAX treated cells (15%), compared to almost all (92%) for cells treated with Paclitaxel alone. Reduction in levels of key cell cycle factor Cyclin-D1 and proliferation marker Ki-67 help clarify the basis for this synergy. These effects are greatly enhanced by loading the drugs into filomicelles. Co-loading the drugs into filomicelles lead to a more potent system compared to separate loading, with no loss in the integration efficiency of drugs. Notably, relapse rates were ~2% three months after treatment, highlighting the improvement offered by filomicelles. The combination retains its potency across multiple cell lines despite their varying responsiveness to RA alone. Drug loaded filomicelles are able to shrink subcutaneous lung and liver tumors in vivo. Tumor shrinkage was also observed with orthotopic liver tumors, leading to a survival benefit. These results highlight the irreversible synergy of killing cancerous cells while driving differentiation.
533 $a Electronic reproduction. $b Ann Arbor, Mich. : $c ProQuest, $d 2018
538 $a Mode of access: World Wide Web
650 4 $a Chemical engineering. $3 555952
650 4 $a Nanotechnology. $3 557660
650 4 $a Oncology. $3 593951
655 7 $a Electronic books. $2 local $3 554714
690 $a 0542
690 $a 0652
690 $a 0992
710 2 $a ProQuest Information and Learning Co. $3 1178819
710 2 $a University of Pennsylvania. $b Chemical and Biomolecular Engineering. $3 1181824
773 0 $t Dissertation Abstracts International $g 79-01B(E).
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10600957 $z click for full text (PQDT)